List of Contents

Medical Radiation Shielding Market Size, Share, and Trends 2024 to 2034

The global medical radiation shielding market size was USD 1.51 billion in 2023, calculated at USD 1.61 billion in 2024 and is expected to be worth around USD 3.08 billion by 2034. The market is slated to expand at 6.70% CAGR from 2024 to 2034.

  • Last Updated : August 2024
  • Report Code : 4868
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Radiation Shielding Market 

5.1. COVID-19 Landscape: Medical Radiation Shielding Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Radiation Shielding Market, By Product Type

8.1. Medical Radiation Shielding Market Revenue and Volume, by Product Type, 2024-2034

8.1.1 X-ray Shields

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. MRI Shields

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Gamma Shields

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

8.1.4. Neutron Shields

8.1.4.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Medical Radiation Shielding Market, By Solution

9.1. Medical Radiation Shielding Market Revenue and Volume, by Solution, 2024-2034

9.1.1. Radiation Therapy Shielding

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Diagnostic Shielding

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Medical Radiation Shielding Market, By End User 

10.1. Medical Radiation Shielding Market Revenue and Volume, by End User, 2024-2034

10.1.1. Hospitals and Diagnostic Centers

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Research Institutes

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Other End Users

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Medical Radiation Shielding Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.1.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.1.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.1.4.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.1.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.1.5.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.1.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.2.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.4.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.2.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.5.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.2.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.6.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.2.6.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.7.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.2.7.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.3.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.4.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.3.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.5.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.3.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.6.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.3.6.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.7.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.3.7.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.4.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.4.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.5.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.4.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.6.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.4.6.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.7.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.4.7.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.5.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.5.4.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.5.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.5.5.2. Market Revenue and Volume Forecast, by Solution (2021-2034)

11.5.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)

Chapter 12. Company Profiles

12.1. A&L Shielding

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Amray Medical

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. ESCO Technologies Inc

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. ETS-Lindgren

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Gaven Industries Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. MAVIG GmbH

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Global Partners in Shielding Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Marshield

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Nelco Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Radiation Protection Products Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client